These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 8598389)

  • 1. Suppression of Theiler's murine encephalomyelitis virus induced demyelinating disease by administration of gangliosides.
    Inoue A; Koh CS; Yanagisawa N; Taketomi T; Ishihara Y
    J Neuroimmunol; 1996 Jan; 64(1):45-53. PubMed ID: 8598389
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phosphatidylserine suppresses Theiler's murine encephalomyelitis virus-induced demyelinating disease.
    Yamazaki M; Inoue A; Koh CS; Sakai T; Ishihara Y
    J Neuroimmunol; 1997 May; 75(1-2):113-22. PubMed ID: 9143244
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High-dose mouse immunoglobulin G administration suppresses Theiler's murine encephalomyelitis virus-induced demyelinating disease.
    Koh C; Inoue A; Yamazaki M; Kim BS
    J Neuroimmunol; 2000 Aug; 108(1-2):22-8. PubMed ID: 10900333
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Suppressive effect on Theiler's murine encephalomyelitis virus-induced demyelinating disease by the administration of anti-IL-12 antibody.
    Inoue A; Koh CS; Yamazaki M; Yahikozawa H; Ichikawa M; Yagita H; Kim BS
    J Immunol; 1998 Nov; 161(10):5586-93. PubMed ID: 9820536
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment with bacterial LPS renders genetically resistant C57BL/6 mice susceptible to Theiler's virus-induced demyelinating disease.
    Pullen LC; Park SH; Miller SD; Dal Canto MC; Kim BS
    J Immunol; 1995 Nov; 155(9):4497-503. PubMed ID: 7594613
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Class II-restricted T cell responses in Theiler's murine encephalomyelitis virus-induced demyelinating disease. V. Mapping of a dominant immunopathologic VP2 T cell epitope in susceptible SJL/J mice.
    Gerety SJ; Karpus WJ; Cubbon AR; Goswami RG; Rundell MK; Peterson JD; Miller SD
    J Immunol; 1994 Jan; 152(2):908-18. PubMed ID: 7904291
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-adhesion molecule therapy in Theiler's murine encephalomyelitis virus-induced demyelinating disease.
    Inoue A; Koh CS; Yamazaki M; Ichikawa M; Isobe M; Ishihara Y; Yagita H; Kim BS
    Int Immunol; 1997 Dec; 9(12):1837-47. PubMed ID: 9466311
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fibrin deposition in the central nervous system correlates with the degree of Theiler's murine encephalomyelitis virus-induced demyelinating disease.
    Inoue A; Koh CS; Yamazaki M; Yanagisawa N; Ishihara Y; Kim BS
    J Neuroimmunol; 1997 Aug; 77(2):185-94. PubMed ID: 9258249
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The TIM-3 pathway ameliorates Theiler's murine encephalomyelitis virus-induced demyelinating disease.
    Kaneyama T; Tomiki H; Tsugane S; Inaba Y; Ichikawa M; Akiba H; Yagita H; Kim BS; Koh CS
    Int Immunol; 2014 Jul; 26(7):369-81. PubMed ID: 24486565
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A predominant viral epitope recognized by T cells from the periphery and demyelinating lesions of SJL/J mice infected with Theiler's virus is located within VP1(233-244).
    Yauch RL; Kim BS
    J Immunol; 1994 Nov; 153(10):4508-19. PubMed ID: 7525707
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Class II-restricted T cell responses in Theiler's murine encephalomyelitis virus-induced demyelinating disease. VI. Potentiation of demyelination with and characterization of an immunopathologic CD4+ T cell line specific for an immunodominant VP2 epitope.
    Gerety SJ; Rundell MK; Dal Canto MC; Miller SD
    J Immunol; 1994 Jan; 152(2):919-29. PubMed ID: 7506740
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Theiler's murine encephalomyelitis virus (TMEV)-induced demyelinating disease in mice is influenced by the H-2D region: correlation with TEMV-specific delayed-type hypersensitivity.
    Clatch RJ; Melvold RW; Miller SD; Lipton HL
    J Immunol; 1985 Aug; 135(2):1408-14. PubMed ID: 3925009
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of the Programmed Death-1 (PD-1) pathway in regulation of Theiler's murine encephalomyelitis virus-induced demyelinating disease.
    Takizawa S; Kaneyama T; Tsugane S; Takeichi N; Yanagisawa S; Ichikawa M; Yagita H; Kim BS; Koh CS
    J Neuroimmunol; 2014 Sep; 274(1-2):78-85. PubMed ID: 25027060
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of Theiler's murine encephalomyelitis virus (TMEV)-specific delayed-type hypersensitivity responses in TMEV-induced demyelinating disease: correlation with clinical signs.
    Clatch RJ; Lipton HL; Miller SD
    J Immunol; 1986 Feb; 136(3):920-7. PubMed ID: 2416841
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression and potential role of inducible nitric oxide synthase in the central nervous system of Theiler's murine encephalomyelitis virus-induced demyelinating disease.
    Iwahashi T; Inoue A; Koh CS; Shin TK; Kim BS
    Cell Immunol; 1999 Jun; 194(2):186-93. PubMed ID: 10383821
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of pentoxifylline (PTX) on Theiler's murine encephalomyelitis (TMEV)-induced demyelinating disease.
    Fushimi T; Inoue A; Koh CS; Yamazaki M; Ishihara Y; Kim BS
    Cell Immunol; 1998 Jun; 186(2):140-6. PubMed ID: 9665756
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of Theiler's virus-mediated demyelination by peripheral immune tolerance induction.
    Karpus WJ; Pope JG; Peterson JD; Dal Canto MC; Miller SD
    J Immunol; 1995 Jul; 155(2):947-57. PubMed ID: 7608570
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Deficient Natural Killer Dendritic Cell Responses Underlay the Induction of Theiler's Virus-Induced Autoimmunity.
    Chastain EM; Getts DR; Miller SD
    mBio; 2015 Aug; 6(4):e01175. PubMed ID: 26242630
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of anti-B7-1 and anti-B7-2 mAb on Theiler's murine encephalomyelitis virus-induced demyelinating disease.
    Inoue A; Koh CS; Yamazaki M; Yagita H
    J Immunol; 1999 Dec; 163(11):6180-6. PubMed ID: 10570309
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interferon-stimulated genes-essential antiviral effectors implicated in resistance to Theiler's virus-induced demyelinating disease.
    Li L; Ulrich R; Baumgärtner W; Gerhauser I
    J Neuroinflammation; 2015 Dec; 12():242. PubMed ID: 26703877
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.